NL-OMON52343招募中不适用
MyopiaX Treatment for the Reduction of Myopia Progression in Children and Adolescents: Safety and Efficacy Investigation - MyopiaX-1
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 至 15（—）
入选标准
- •- Myopic children (-0.75 to -5.0 D SER, least myopic meridian -0.50 D in each
- •- At least VA 0.2 LogMAR in each eye
- •- Age: 6 - 12 years old
- •- Good tolerability of test session with VR system
- •- Binocular adequacy as tested with VR
- •- Ability to understand treatment and give valid assent
排除标准
- •- Concomitant or previous therapies for myopia
- •-Eye diseases/conditions:
- •- Anisometropia >= 1.5 D
- •- Astigmatism >= 3 D
- •- Ophthalmological comorbidities
- •- Optic nerve abnormalities
- •- Suspicion of syndromic or monogenetic myopia
- •- Systemic illnesses affecting eye health, eye growth, and/or refraction
- •- Any illnesses affecting dopamine function (e.g., sleep
- •disorder, ADHD, Parkinson Disease, and autism spectrum
- •- Medication affecting dopamine function, accommodation, pupil size, or having
- •an impact on the ocular surface (topical ocular medications)
- •- Participation in other clinical studies
- •- Medical history (or family history) of photosensitive epilepsy
研究者
相似试验
已完成
不适用
MyopiaX Treatment for the Reduction of Myopia Progression in Children and Adolescents: Safety and Efficacy InvestigationMyopiaNCT04967287Dopavision GmbH124
已完成
不适用
Dissection of the etiology of myopia and efficacy and safety of an Artisan phakic iris-claw intraocular lens for the correction of high myopiasevere nearsightedness10047060high myopiaNL-OMON45140Erasmus MC, Universitair Medisch Centrum Rotterdam1,400
进行中（未招募）
1 期
ow-dose AtropIne for Myopia control in childreEUCTR2020-001575-33-DEniversitätsklinikum Freiburg300
招募中
不适用
Suppression of myopia progression by low dose atropineChildhood MyopiaJPRN-UMIN000028768Tokyo Medical and Dental University80
尚未招募
3 期
Myopia-Prevalence and managementCTRI/2023/03/051207Govt of Kerala